SLC16A1 and cancer: The poor prognosis of multiple types of cancers is associated with high expression of MCT1 and MCT4, such as glioma (72), breast cancer (73), non-small cell lung cancer (74), colorectal cancer (75), gastric cancer (76), cervical cancer (77) and neuroblastoma (78).